title: A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex.
authors.forename: Mari
authors.initials: M
authors.lastname: Wataya-Kaneda
authors.forename: Mari
authors.initials: M
authors.lastname: Tanaka
authors.forename: Ayumi
authors.initials: A
authors.lastname: Nakamura
authors.forename: Shoji
authors.initials: S
authors.lastname: Matsumoto
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
mesh_terms: D000287:Administration, Topical; D002648:Child; D002675:Child, Preschool; D006801:Humans; D017496:Hypopigmentation / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D014402:Tuberous Sclerosis / Q000150:complications
chemical_list: C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus